What is CAR-T?

Learn more about the CAR-T Therapy
and CAR-T Technology

What is CAR-T?

Learn more about the CAR-T Therapy
and CAR-T Technology

What is CAR-T?

Learn more about the CAR-T Therapy
and CAR-T Technology

circle_registration

This webcast is for you who come in contact with patients with Hematological Malignancies. The webcast will cover The History of CAR-T and Key Milestones, Overview of CAR-T Therapy and the Overview of Patient Experience, Basic CAR Engineering Principles and The Evolution of CAR Design. Bring your lunch with you and participate in the meeting. At the end you will have the opportunity to ask questions to the Faculty.

Learning objectives: After this event, participants should know more about:
  • CAR-T construct design which is an evolving process, and differences in
    construct design may affect efficacy and safety of the product
  • The Overview of CAR-T Therapy
  • The Overview of Patient Experience
  • Basic CAR Engineering Principles
  • The Evolution of CAR Design
Fredrik Jerhammar
Nordic Medical Advisor
Janssen Cell Therapy Department
Åse Rosenqvist
Nordic Business Unit Lead Cell Therapy
Janssen Cell Therapy Department

Åse Rosenqvist

Nordic Business Unit
Lead Cell Therapy
Janssen-Cilag AB
Mobile: +46 738 03 92 54
arosenq1@its.jnj.com

Fredrik Jerhammar

Nordic Medical Advisor
Cell Therapy
Janssen-Cilag AB
Mobile: +46 738 24 34 61
fjerhamm@its.jnj.com

Upcoming Webinars

Bo. Nam am eicte pro quunt omnime diosaer eptam, sus. Ibus, nonectae nos autatem int ressequi offic totat vel inulparum que nus. Niscianimo bla il ea quo corum fugiant et et quatiundae eritatius vellum a cus aut labo. Nemporeicae quame mod magnati aspedi temporecto cus, ut est quis ium dolorpo ssequiatur mincilia eos

Recorded Webinars

Bo. Nam am eicte pro quunt omnime diosaer eptam, sus. Ibus, nonectae nos autatem int ressequi offic totat vel inulparum que nus. Niscianimo bla il ea quo corum fugiant et et quatiundae eritatius vellum a cus aut labo. Nemporeicae quame mod magnati aspedi temporecto cus, ut est quis ium dolorpo ssequiatur mincilia eos

Janssen Cell Therapy Team

Bo. Nam am eicte pro quunt omnime diosaer eptam, sus. Ibus, nonectae nos autatem int ressequi offic totat vel inulparum que nus. Niscianimo bla il ea quo corum fugiant et et quatiundae eritatius vellum a cus aut labo. Nemporeicae quame mod magnati aspedi temporecto cus, ut est quis ium dolorpo ssequiatur mincilia eos

Webinar #1:
What is CAR-T

Date: Tuesday,
October 17, 2023
Time: 15.00–16.00

Webinar #2:
CAR-T Certification

Date: Tuesday,
November 21, 2023
Time: 15.00–16.00

Webinar #3:
Post – ASH & CAR-T

Date: Tuesday,
January 23, 2024
Time: 15.00–16.00

Webinar #4:
Janssen Manufacturing

Date: Tuesday,
February 20, 2024
Time: 15.00–16.00

Webinar #5:
Apheresis

Date: Tuesday,
March 26, 2024
Time: 15.00–16.00

Webinar #6:
Patient Selection

Date: Tuesday,
April 23, 2024
Time: 15.00–16.00

Thursday, November 16, 2023
15:00–16:00 CET 

What is

CAR-T?

Learn more about the CAR-T Therapy
and CAR-T Technology

Agenda

15:00 Welcome & Introduction
Åse Rosenqvist
15:05What is CAR-T?
Fredrik Jerhammar
15:40Q&A
15:55 Summary
Åse Rosenqvist
16:00Closing
Webinar November 16, 2023
Deadline for registration is November 13, 2023
Please remember: It’s the delegate’s responsibility to inform the employer about participation in the meeting.

There is no cost for this webcast as it is sponsored by Janssen.

If you have any questions, please contact:

Åse Rosenqvist
Nordic Business Unit
Lead Cell Therapy
Mobile: +46 738 03 92 54

Education